10.3184/030823407X225473
The research presents the synthesis and anti-hepatitis B virus (HBV) activity of isocytosine derivatives linked to the 5-position of methyl β-D-ribofuranoside. The study involves the synthesis of a series of isocytosine derivatives through a multi-step process, utilizing reactants such as d-ribose, tosylation reagents, potassium phthalimide, and various 2-methyl-thiouracils. The synthesized compounds were evaluated for in vitro cytotoxicity against HBV, with some showing moderate activity. The experiments included nucleophilic substitution reactions, deprotection steps using acids like 70% AcOH, and purification through chromatographic techniques. The structures and purities of the synthesized compounds were confirmed using techniques like 1H NMR spectroscopy, EI-MS, and elemental analysis. The anti-HBV activity was screened using the Hep G2 2.2.15 cell method, revealing selective indexes for the compounds that indicated their potential as antiviral agents.